Elizabeth Yeu Lin
Chief Medical Officer at Tarsus Pharmaceuticals, Inc. (TARS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 9SEC | TARSTarsus Pharmaceuticals, Inc. | Sell Plan | 5,3877,933 held (−40%) | $85.00 | $458K | -13.9% |
| Sep 9SEC | TARSTarsus Pharmaceuticals, Inc. | Sell Plan | 5,3862,547 held (−68%) | $90.00 | $485K | -18.7% |
| Sep 9SEC | TARSTarsus Pharmaceuticals, Inc. | Sell Plan | 1,5903,180 held (−33%) | $85.00 | $135K | -13.9% |
| Sep 9SEC | TARSTarsus Pharmaceuticals, Inc. | Sell Plan | 1,5901,590 held (−50%) | $90.00 | $143K | -18.7% |
| Sep 3SEC | TARSTarsus Pharmaceuticals, Inc. | Sell Plan | 4,60118,707 held (−20%) | $73.86 | $340K | -0.9% |
| Sep 3SEC | TARSTarsus Pharmaceuticals, Inc. | Sell Plan | 5,38713,320 held (−29%) | $80.00 | $431K | -8.6% |
| Sep 3SEC | TARSTarsus Pharmaceuticals, Inc. | Sell Plan | 1,5904,770 held (−25%) | $80.00 | $127K | -8.6% |
| Mar 19SEC | TARSTarsus Pharmaceuticals, Inc. | Sell | 37524,077 held (−2%) | $69.42 | $26K | +5.4% |
| Mar 19SEC | TARSTarsus Pharmaceuticals, Inc. | Sell | 37923,698 held (−2%) | $68.71 | $26K | +6.5% |
| Mar 19SEC | TARSTarsus Pharmaceuticals, Inc. | Sell | 39023,308 held (−2%) | $67.00 | $26K | +9.2% |
| Dec 17SEC | TARSTarsus Pharmaceuticals, Inc. | Sell | 2,07821,941 held (−9%) | $79.50 | $165K | -8.0% |
- Sell
Chief Medical Officer Elizabeth Yeu Lin sold $458K of TARS at $85.00 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Elizabeth Yeu Lin sold $485K of TARS at $90.00 — cuts the stake by 68%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Elizabeth Yeu Lin sold $135K of TARS at $85.00 — cuts the stake by 33%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Elizabeth Yeu Lin sold $143K of TARS at $90.00 — cuts the stake by 50%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Elizabeth Yeu Lin sold $340K of TARS at $73.86 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Elizabeth Yeu Lin sold $431K of TARS at $80.00 — cuts the stake by 29%; pre-scheduled 10b5-1 plan sale.